Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCNT1 | O60563 | 19/20 | 0.69 |
| ▸ | CCNK | O75909 | 19/20 | 0.69 |
| ▸ | CDK9 | P50750 | 19/20 | 0.69 |
| ▸ | CDK12 | Q9NYV4 | 19/20 | 0.69 |
| ▸ | CDK7 | P50613 | 8/20 | 0.69 |
| ▸ | CCNH | P51946 | 8/20 | 0.69 |
| ▸ | MNAT1 | P51948 | 5/20 | 0.69 |
| ▸ | CCNE1 | P24864 | 16/20 | 0.67 |
| ▸ | CDK2 | P24941 | 16/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30261019 | 0.91 | CCNT1 (0.68) | CCNT1CCNKCDK9CDK12CDK7 | |
| SCHEMBL30260922 | 0.89 | CCNT1 (0.76) | CCNT1CCNKCDK9CDK12CDK7 | |
| SCHEMBL30260993 | 0.88 | CCNK (0.70) | CCNT1CCNKCDK9CDK12CDK7 | |
| SCHEMBL30260859 | 0.88 | CCNT1 (0.66) | CCNT1CCNKCDK9CDK12CDK7 | |
| SCHEMBL30260953 | 0.86 | CCNT1 (0.75) | CCNT1CCNKCDK9CDK12CDK7 | |
| SCHEMBL25582726 | 0.86 | CCNT1 (0.80) | CCNT1CCNKCDK9CDK12CDK7 | |
| SCHEMBL25591347 | 0.85 | CCNT1 (0.76) | CCNT1CCNKCDK9CDK12CDK7 | |
| SCHEMBL30260911 | 0.85 | CCNT1 (0.68) | CCNT1CCNKCDK9CDK12CDK7 | |
| SCHEMBL25594109 | 0.84 | CCNT1 (0.67) | CCNT1CCNKCDK9CDK12CDK7 | |
| SCHEMBL25594066 | 0.84 | CCNT1 (0.67) | CCNT1CCNKCDK9CDK12CDK7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023040998-A1 | A CYCLIN-DEPENDENT KINASE INHIBITOR | Taizhou Eoc Pharma Co., Ltd. (CN) | 2023-03-23 | — | — | WO | disclosed |